Mary-Ellen Lynall, Peter B. Jones, Stephen M. Stahl
Cambridge Textbook of Neuroscience for Psychiatrists
101,99 €
inkl. MwSt.
Versandkostenfrei*
Verlag / Hersteller kann z. Zt. nicht liefern
Melden Sie sich
hier
hier
für den Produktalarm an, um über die Verfügbarkeit des Produkts informiert zu werden.
51 °P sammeln
Mary-Ellen Lynall, Peter B. Jones, Stephen M. Stahl
Cambridge Textbook of Neuroscience for Psychiatrists
- Broschiertes Buch
"In the past 100 years, there has been a revolution in our understanding of the brain. So far, this has done little to disrupt mainstream psychiatric practice. That is set to change. New neuroscience-based treatments are emerging, while evidence from neuroscience and genetics are calling into question traditional diagnostic boundaries. Psychiatrists of the future will need to integrate their understanding of brain imaging, molecular diagnostics, psychological factors and social context to provide neuroscience-informed care plans"--
Andere Kunden interessierten sich auch für
- Cambridge Prescriber's Guide in Psychiatry49,99 €
- DANIEL J. CARLATThe Psychiatric Interview67,99 €
- Oliver SacksThe Man Who Mistook His Wife for a Hat20,99 €
- Oliver SacksThe Man Who Mistook His Wife for a Hat9,99 €
- Laura Scarrone BonhommeGender Affirming Therapy: A Guide to What Transgender and Non-Binary Clients Can Teach Us22,99 €
- Stephen M. Stahl (San Diego University of California)Stahl's Illustrated Pharmacological Treatments for Psychosis49,99 €
- Robert BolandKaplan & Sadock's Concise Textbook of Clinical Psychiatry95,99 €
-
-
-
"In the past 100 years, there has been a revolution in our understanding of the brain. So far, this has done little to disrupt mainstream psychiatric practice. That is set to change. New neuroscience-based treatments are emerging, while evidence from neuroscience and genetics are calling into question traditional diagnostic boundaries. Psychiatrists of the future will need to integrate their understanding of brain imaging, molecular diagnostics, psychological factors and social context to provide neuroscience-informed care plans"--
Produktdetails
- Produktdetails
- Verlag: RCPsych/Cambridge University Press
- Seitenzahl: 598
- Erscheinungstermin: Dezember 2023
- Englisch
- Abmessung: 244mm x 192mm x 32mm
- Gewicht: 1324g
- ISBN-13: 9781911623113
- ISBN-10: 1911623117
- Artikelnr.: 69021713
- Verlag: RCPsych/Cambridge University Press
- Seitenzahl: 598
- Erscheinungstermin: Dezember 2023
- Englisch
- Abmessung: 244mm x 192mm x 32mm
- Gewicht: 1324g
- ISBN-13: 9781911623113
- ISBN-10: 1911623117
- Artikelnr.: 69021713
I. Cells: 1.1. Neurons
1.2. The physiology of neurons, synapses and receptors
1.3. Modelling single neurons and their combinations in circuits
1.4. Glia
II. Neurotransmitters and Receptors: 2.1. The chemical synapse
2.2. Classification of receptors: metabotropic and ionotropic receptors
2.3. Neuronal receptors and drug targets
2.4. Basic pharmacology of specific neurotransmitter pathways
2.5. Neuropeptides
2.6. Genetic association studies and neurotransmitter pathways
2.7. Opioids and common recreational drugs
III. Basic Techniques in Neuroscience: 3.1. Recording from the brain
3.2. Perturbing brain function
3.3. Animal models of psychiatric disease
3.4. Data analysis and computational modelling
3.5. Functional neuroimaging and connectivity
IV. Neuroanatomy: 4.1. Fundamentals
4.2. The basal ganglia
4.3. The temporal lobes
4.4. The frontal lobes
4.5. White matter pathways
4.6. Ascending neurotransmitter systems
V. Neural Circuits: 5.1. Appetite
5.2. Sleep
5.3. Sex and sex hormones
5.4. Violence and aggression
5.5. Nociception and pain
5.6. The motor system and movement disorders
5.7. Computational models of learning
5.8. Habit formation
5.9. Reward, pleasure and motivation
5.10. Emotion
5.11. Perception
5.12. Attention
5.13. Apathy, anhedonia and fatigue
5.14. Memory
5.15. Fronto-executive functions
5.16. Empathy and theory of mind
5.17. Language
5.18. Brain networks and dysconnectivity
VI. Modulators: 6.1. The hypothalamic-pituitary (Neuroendocrine) axis
6.2. The stress response and glucocorticoids
6.3. Adrenal steroids
6.4. Inflammation and immune responses
VII. Genetics: 7.1. Basic genetic principles and the history of gene identification
7.2. Common variation
7.3. Rare variation
7.4. Epigenetics
7.5. The clinical application of genetics in psychiatry
VIII. Neurodevelopment and Neuroplasticity: 8.1. The development of brain structure and function
8.2. Neurodevelopmental models of psychiatric disorders
8.3. Attachment
8.4. Neuroplasticity
8.5. Intelligence and intellectual disability
IX. Integrated Neurobiology of Specific Syndromes and Treatments: 9.1. Autism
9.2. Attention deficit hyperactivity disorder
9.3. Drug use, addiction, tolerance, withdrawal and relapse
9.4. Anxiety disorders
9.5. Post-traumatic stress disorder
9.6. Obsessive-compulsive and related disorders
9.7. Major depressive disorder
9.8. Bipolar affective disorder
9.9. Psychosis
9.10. Schizophrenia
9.11. Borderline personality disorder
9.12. Self-harm and suicidality
9.13. Medically unexplained symptoms
9.14. Delirium
9.15. Perinatal disorders
9.16. Sleep disorders
9.17. Eating disorders
9.18. Epilepsy and seizures
9.19. Electroconvulsive therapy
9.20. Brain stimulation
X. Neurodegeneration: 10.1. A neurodegenerative cascade of causality
10.2. Prodromal disease and mild cognitive impairment
10.3. Preclinical stages of neurodegenerative disease
10.4. Spectra, domains and dimensions of neurodegenerative disease
10.5. Reserve, resilience and resistance to neurodegeneration
10.6. Environmental causes of neurodegenerative disease
10.7. Morbidity and dual pathology in neurodegenerative disorders.
1.2. The physiology of neurons, synapses and receptors
1.3. Modelling single neurons and their combinations in circuits
1.4. Glia
II. Neurotransmitters and Receptors: 2.1. The chemical synapse
2.2. Classification of receptors: metabotropic and ionotropic receptors
2.3. Neuronal receptors and drug targets
2.4. Basic pharmacology of specific neurotransmitter pathways
2.5. Neuropeptides
2.6. Genetic association studies and neurotransmitter pathways
2.7. Opioids and common recreational drugs
III. Basic Techniques in Neuroscience: 3.1. Recording from the brain
3.2. Perturbing brain function
3.3. Animal models of psychiatric disease
3.4. Data analysis and computational modelling
3.5. Functional neuroimaging and connectivity
IV. Neuroanatomy: 4.1. Fundamentals
4.2. The basal ganglia
4.3. The temporal lobes
4.4. The frontal lobes
4.5. White matter pathways
4.6. Ascending neurotransmitter systems
V. Neural Circuits: 5.1. Appetite
5.2. Sleep
5.3. Sex and sex hormones
5.4. Violence and aggression
5.5. Nociception and pain
5.6. The motor system and movement disorders
5.7. Computational models of learning
5.8. Habit formation
5.9. Reward, pleasure and motivation
5.10. Emotion
5.11. Perception
5.12. Attention
5.13. Apathy, anhedonia and fatigue
5.14. Memory
5.15. Fronto-executive functions
5.16. Empathy and theory of mind
5.17. Language
5.18. Brain networks and dysconnectivity
VI. Modulators: 6.1. The hypothalamic-pituitary (Neuroendocrine) axis
6.2. The stress response and glucocorticoids
6.3. Adrenal steroids
6.4. Inflammation and immune responses
VII. Genetics: 7.1. Basic genetic principles and the history of gene identification
7.2. Common variation
7.3. Rare variation
7.4. Epigenetics
7.5. The clinical application of genetics in psychiatry
VIII. Neurodevelopment and Neuroplasticity: 8.1. The development of brain structure and function
8.2. Neurodevelopmental models of psychiatric disorders
8.3. Attachment
8.4. Neuroplasticity
8.5. Intelligence and intellectual disability
IX. Integrated Neurobiology of Specific Syndromes and Treatments: 9.1. Autism
9.2. Attention deficit hyperactivity disorder
9.3. Drug use, addiction, tolerance, withdrawal and relapse
9.4. Anxiety disorders
9.5. Post-traumatic stress disorder
9.6. Obsessive-compulsive and related disorders
9.7. Major depressive disorder
9.8. Bipolar affective disorder
9.9. Psychosis
9.10. Schizophrenia
9.11. Borderline personality disorder
9.12. Self-harm and suicidality
9.13. Medically unexplained symptoms
9.14. Delirium
9.15. Perinatal disorders
9.16. Sleep disorders
9.17. Eating disorders
9.18. Epilepsy and seizures
9.19. Electroconvulsive therapy
9.20. Brain stimulation
X. Neurodegeneration: 10.1. A neurodegenerative cascade of causality
10.2. Prodromal disease and mild cognitive impairment
10.3. Preclinical stages of neurodegenerative disease
10.4. Spectra, domains and dimensions of neurodegenerative disease
10.5. Reserve, resilience and resistance to neurodegeneration
10.6. Environmental causes of neurodegenerative disease
10.7. Morbidity and dual pathology in neurodegenerative disorders.
I. Cells: 1.1. Neurons
1.2. The physiology of neurons, synapses and receptors
1.3. Modelling single neurons and their combinations in circuits
1.4. Glia
II. Neurotransmitters and Receptors: 2.1. The chemical synapse
2.2. Classification of receptors: metabotropic and ionotropic receptors
2.3. Neuronal receptors and drug targets
2.4. Basic pharmacology of specific neurotransmitter pathways
2.5. Neuropeptides
2.6. Genetic association studies and neurotransmitter pathways
2.7. Opioids and common recreational drugs
III. Basic Techniques in Neuroscience: 3.1. Recording from the brain
3.2. Perturbing brain function
3.3. Animal models of psychiatric disease
3.4. Data analysis and computational modelling
3.5. Functional neuroimaging and connectivity
IV. Neuroanatomy: 4.1. Fundamentals
4.2. The basal ganglia
4.3. The temporal lobes
4.4. The frontal lobes
4.5. White matter pathways
4.6. Ascending neurotransmitter systems
V. Neural Circuits: 5.1. Appetite
5.2. Sleep
5.3. Sex and sex hormones
5.4. Violence and aggression
5.5. Nociception and pain
5.6. The motor system and movement disorders
5.7. Computational models of learning
5.8. Habit formation
5.9. Reward, pleasure and motivation
5.10. Emotion
5.11. Perception
5.12. Attention
5.13. Apathy, anhedonia and fatigue
5.14. Memory
5.15. Fronto-executive functions
5.16. Empathy and theory of mind
5.17. Language
5.18. Brain networks and dysconnectivity
VI. Modulators: 6.1. The hypothalamic-pituitary (Neuroendocrine) axis
6.2. The stress response and glucocorticoids
6.3. Adrenal steroids
6.4. Inflammation and immune responses
VII. Genetics: 7.1. Basic genetic principles and the history of gene identification
7.2. Common variation
7.3. Rare variation
7.4. Epigenetics
7.5. The clinical application of genetics in psychiatry
VIII. Neurodevelopment and Neuroplasticity: 8.1. The development of brain structure and function
8.2. Neurodevelopmental models of psychiatric disorders
8.3. Attachment
8.4. Neuroplasticity
8.5. Intelligence and intellectual disability
IX. Integrated Neurobiology of Specific Syndromes and Treatments: 9.1. Autism
9.2. Attention deficit hyperactivity disorder
9.3. Drug use, addiction, tolerance, withdrawal and relapse
9.4. Anxiety disorders
9.5. Post-traumatic stress disorder
9.6. Obsessive-compulsive and related disorders
9.7. Major depressive disorder
9.8. Bipolar affective disorder
9.9. Psychosis
9.10. Schizophrenia
9.11. Borderline personality disorder
9.12. Self-harm and suicidality
9.13. Medically unexplained symptoms
9.14. Delirium
9.15. Perinatal disorders
9.16. Sleep disorders
9.17. Eating disorders
9.18. Epilepsy and seizures
9.19. Electroconvulsive therapy
9.20. Brain stimulation
X. Neurodegeneration: 10.1. A neurodegenerative cascade of causality
10.2. Prodromal disease and mild cognitive impairment
10.3. Preclinical stages of neurodegenerative disease
10.4. Spectra, domains and dimensions of neurodegenerative disease
10.5. Reserve, resilience and resistance to neurodegeneration
10.6. Environmental causes of neurodegenerative disease
10.7. Morbidity and dual pathology in neurodegenerative disorders.
1.2. The physiology of neurons, synapses and receptors
1.3. Modelling single neurons and their combinations in circuits
1.4. Glia
II. Neurotransmitters and Receptors: 2.1. The chemical synapse
2.2. Classification of receptors: metabotropic and ionotropic receptors
2.3. Neuronal receptors and drug targets
2.4. Basic pharmacology of specific neurotransmitter pathways
2.5. Neuropeptides
2.6. Genetic association studies and neurotransmitter pathways
2.7. Opioids and common recreational drugs
III. Basic Techniques in Neuroscience: 3.1. Recording from the brain
3.2. Perturbing brain function
3.3. Animal models of psychiatric disease
3.4. Data analysis and computational modelling
3.5. Functional neuroimaging and connectivity
IV. Neuroanatomy: 4.1. Fundamentals
4.2. The basal ganglia
4.3. The temporal lobes
4.4. The frontal lobes
4.5. White matter pathways
4.6. Ascending neurotransmitter systems
V. Neural Circuits: 5.1. Appetite
5.2. Sleep
5.3. Sex and sex hormones
5.4. Violence and aggression
5.5. Nociception and pain
5.6. The motor system and movement disorders
5.7. Computational models of learning
5.8. Habit formation
5.9. Reward, pleasure and motivation
5.10. Emotion
5.11. Perception
5.12. Attention
5.13. Apathy, anhedonia and fatigue
5.14. Memory
5.15. Fronto-executive functions
5.16. Empathy and theory of mind
5.17. Language
5.18. Brain networks and dysconnectivity
VI. Modulators: 6.1. The hypothalamic-pituitary (Neuroendocrine) axis
6.2. The stress response and glucocorticoids
6.3. Adrenal steroids
6.4. Inflammation and immune responses
VII. Genetics: 7.1. Basic genetic principles and the history of gene identification
7.2. Common variation
7.3. Rare variation
7.4. Epigenetics
7.5. The clinical application of genetics in psychiatry
VIII. Neurodevelopment and Neuroplasticity: 8.1. The development of brain structure and function
8.2. Neurodevelopmental models of psychiatric disorders
8.3. Attachment
8.4. Neuroplasticity
8.5. Intelligence and intellectual disability
IX. Integrated Neurobiology of Specific Syndromes and Treatments: 9.1. Autism
9.2. Attention deficit hyperactivity disorder
9.3. Drug use, addiction, tolerance, withdrawal and relapse
9.4. Anxiety disorders
9.5. Post-traumatic stress disorder
9.6. Obsessive-compulsive and related disorders
9.7. Major depressive disorder
9.8. Bipolar affective disorder
9.9. Psychosis
9.10. Schizophrenia
9.11. Borderline personality disorder
9.12. Self-harm and suicidality
9.13. Medically unexplained symptoms
9.14. Delirium
9.15. Perinatal disorders
9.16. Sleep disorders
9.17. Eating disorders
9.18. Epilepsy and seizures
9.19. Electroconvulsive therapy
9.20. Brain stimulation
X. Neurodegeneration: 10.1. A neurodegenerative cascade of causality
10.2. Prodromal disease and mild cognitive impairment
10.3. Preclinical stages of neurodegenerative disease
10.4. Spectra, domains and dimensions of neurodegenerative disease
10.5. Reserve, resilience and resistance to neurodegeneration
10.6. Environmental causes of neurodegenerative disease
10.7. Morbidity and dual pathology in neurodegenerative disorders.